湖(hu)(hu)北亨(heng)迪藥(yao)(yao)業(ye)(ye)股份有(you)(you)(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)于(yu)(yu)2020年6月28日由湖(hu)(hu)北百(bai)(bai)科(ke)(ke)亨(heng)迪藥(yao)(yao)業(ye)(ye)有(you)(you)(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)改制更名而來,現有(you)(you)(you)員工900多(duo)人。主(zhu)要從事醫藥(yao)(yao)原(yuan)料(liao)藥(yao)(yao)和(he)制劑產品的研(yan)發(fa)、生產和(he)銷售(shou)(shou)。注冊(ce)地(di)和(he)生產基(ji)地(di)設(she)于(yu)(yu)湖(hu)(hu)北荊(jing)門,研(yan)發(fa)和(he)銷售(shou)(shou)中心設(she)于(yu)(yu)武(wu)(wu)漢。公(gong)(gong)(gong)(gong)司(si)(si)下設(she)3個子公(gong)(gong)(gong)(gong)司(si)(si):武(wu)(wu)漢百(bai)(bai)科(ke)(ke)藥(yao)(yao)物開發(fa)有(you)(you)(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)、武(wu)(wu)漢亨(heng)迪藥(yao)(yao)物開發(fa)有(you)(you)(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)、湖(hu)(hu)北百(bai)(bai)科(ke)(ke)醫藥(yao)(yao)商貿有(you)(you)(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si),1個分公(gong)(gong)(gong)(gong)司(si)(si):湖(hu)(hu)北亨(heng)迪藥(yao)(yao)業(ye)(ye)股份有(you)(you)(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)研(yan)究(jiu)院分公(gong)(gong)(gong)(gong)司(si)(si)。公(gong)(gong)(gong)(gong)司(si)(si)是湖(hu)(hu)北省(sheng)高新技術企業(ye)(ye)、湖(hu)(hu)北省(sheng)博(bo)士后創新實踐(jian)基(ji)地(di)、華中科(ke)(ke)技大(da)學(xue)同(tong)濟醫學(xue)院藥(yao)(yao)學(xue)教學(xue)基(ji)地(di)、湖(hu)(hu)北省(sheng)2020年新冠肺炎抗疫6家(jia)知(zhi)名保供企業(ye)(ye)之一(yi)。
公(gong)司是(shi)全(quan)球(qiu)六(liu)大主(zhu)要布(bu)(bu)洛芬(fen)原(yuan)(yuan)料(liao)藥(yao)生產(chan)企業之一、國內重要的(de)解(jie)熱鎮痛(tong)原(yuan)(yuan)料(liao)藥(yao)基地(di)(di)、湖(hu)北省抗腫瘤特色(se)原(yuan)(yuan)料(liao)藥(yao)基地(di)(di)和(he)固體制劑(ji)(ji)制造基地(di)(di),擁有50多(duo)個醫藥(yao)原(yuan)(yuan)料(liao)藥(yao)和(he)制劑(ji)(ji)品(pin)規(gui),其中解(jie)熱鎮痛(tong)原(yuan)(yuan)料(liao)藥(yao)布(bu)(bu)洛芬(fen)年產(chan)能(neng)3500噸,產(chan)品(pin)客戶遍及(ji)全(quan)世(shi)界(jie)80多(duo)個國家(jia)和(he)地(di)(di)區;右旋布(bu)(bu)洛芬(fen)年產(chan)能(neng)200噸,托拉塞(sai)米年產(chan)能(neng)10噸,醋酸阿比特龍年產(chan)能(neng)4噸,以及(ji)多(duo)個CDMO車間;固體制劑(ji)(ji)年產(chan)能(neng)10億片片劑(ji)(ji)、3億粒(li)膠囊、1億袋顆粒(li)劑(ji)(ji)。
公司目前共有十幾個(ge)(ge)品種在歐美(mei)進行了注冊,荊門和武漢兩個(ge)(ge)基地共十一(yi)次通過(guo)(guo)歐美(mei)藥監局檢查(cha)認(ren)證,是國內(nei)同(tong)時(shi)通過(guo)(guo)歐美(mei)GMP認(ren)證檢查(cha)的為數不多企業之一(yi)。
公司(si)堅持原(yuan)料(liao)藥為(wei)主(zhu),做精做強,將公司(si)打(da)造和(he)建設成(cheng)為(wei)國內重要的非(fei)甾體抗炎(yan)類(lei)原(yuan)料(liao)藥和(he)特(te)色原(yuan)料(liao)藥生(sheng)產基(ji)地,將進一(yi)步發(fa)力布局原(yuan)料(liao)藥CDMO和(he)制劑業務,實現原(yuan)料(liao)藥與制劑兩個(ge)板塊協同發(fa)展。